29 September 2017 EMA/641530/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: omega-3-acid-ethyl esters

Procedure no.: PSUSA/00010312/201701

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Dualtis 1000 mg

FR/H/0261/001

PL 15905/0002

PRONOVA BIOPHARMA

UK

capsules, soft Dualtis 1000 mg meke

NORGE AS not available

UP/I-530-09/12-01/152

MYLAN HRVATSKA D.O.O.

HR

not available

027617024

PFIZER ITALIA S.R.L.

IT

not available

027617012

PFIZER ITALIA S.R.L.

IT

not available

027618040

SIGMA-TAU INDUSTRIE

IT

kapsule ESAPENT 1000 mg Capsule molli ESAPENT 500 mg Capsule molli ESKIM 1000 mg capsule molli

FARMACEUTICHE RIUNITE S.P.A.

ESKIM 1000 mg capsule

not available

027618053

molli

SIGMA-TAU INDUSTRIE

IT

FARMACEUTICHE RIUNITE S.P.A.

ESKIM 500 mg capsule

not available

027618038

molli

SIGMA-TAU INDUSTRIE

IT

FARMACEUTICHE RIUNITE S.P.A.

Omacor 1000 mg

FR/H/0105/001

65.476

cápsulas blandas Omacor 1000 mg

ES

NORGE AS FR/H/0105/001

BE253066

capsules molles Omacor 1000 mg

PRONOVA BIOPHARMA

PRONOVA BIOPHARMA

BE

NORGE AS FR/H/105/01

capsules molles

List of nationally authorised medicinal products EMA/639207/2017

2011071232

PRONOVA BIOPHARMA

LU

NORGE AS

Page 2/10

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Omacor 1000 mg lágy

FR/H/105/01

OGYI-T-9691/01

PRONOVA BIOPHARMA

HU

kapzula Omacor 1000 mg lágy

NORGE AS FR/H/105/01

OGYI-T-9691/02

kapzula Omacor 1000 mg lágy

FR/H/105/01

OGYI-T-9691/03

FR/H/0105/001

31/0378/05-S

FR/H/105/01

H/05/01172/001

FR/H/0105/001

H/05/01172/002

FR/H/0105/001

H/05/01172/003

PRONOVA BIOPHARMA

SI

PRONOVA BIOPHARMA

SI

PRONOVA BIOPHARMA

SI

NORGE AS FR/H/0105/001

H/05/01172/004

kapsule Omacor 1000 mg mehke

SK

NORGE AS

kapsule Omacor 1000 mg mehke

PRONOVA BIOPHARMA

NORGE AS

kapsule Omacor 1000 mg mehke

HU

NORGE AS

kapsule Omacor 1000 mg mehke

PRONOVA BIOPHARMA NORGE AS

kapsuly Omacor 1000 mg mehke

HU

NORGE AS

kapzula Omacor 1000 mg mäkké

PRONOVA BIOPHARMA

PRONOVA BIOPHARMA

SI

NORGE AS FR/H/0105/001

kapsule

List of nationally authorised medicinal products EMA/639207/2017

H/05/01172/005

PRONOVA BIOPHARMA

SI

NORGE AS

Page 3/10

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Omacor 1000 mg mehke

FR/H/0105/001

H/05/01172/006

PRONOVA BIOPHARMA

SI

kapsule Omacor 1000 mg meke

NORGE AS not available

HR-H-239310133

MYLAN HRVATSKA D.O.O.

HR

FR/H/0105/001

05-0465

PRONOVA BIOPHARMA

LV

kapsule Omacor 1000 mg mīkstās kapsulas Omacor 1000 mg

NORGE AS FR/H/0105/001

LT/1/05/0319/003

minkštosios kapsules Omacor 1000 mg

FR/H/0105/001

LT/1/05/0319/001

FR/H/0105/001

LT/1/05/0319/004

FR/H/0105/001

LT/1/05/0319/002

PRONOVA BIOPHARMA

LT

PRONOVA BIOPHARMA

LT

NORGE AS FR/H/0105/001

LT/1/05/0319/005

minkštosios kapsules Omacor 1000 mg Soft

LT

NORGE AS

minkštosios kapsules Omacor 1000 mg

PRONOVA BIOPHARMA NORGE AS

minkštosios kapsules Omacor 1000 mg

LT

NORGE AS

minkštosios kapsules Omacor 1000 mg

PRONOVA BIOPHARMA

PRONOVA BIOPHARMA

LT

NORGE AS FR/H/0105/001

Capsules

List of nationally authorised medicinal products EMA/639207/2017

1099/1/1

PRONOVA BIOPHARMA

IE

NORGE AS

Page 4/10

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Omacor 1000 mg

FR/H/0105/001

1-21530

PRONOVA BIOPHARMA

AT

Weichkapseln Omacor 1000 mg

NORGE AS FR/H/0105/001

BE253066

Weichkapseln Omacor 1000 mg

FR/H/0105/001

2011071232

FR/H/0105/001

BE253066

FR/H/0105/001

5336888

FR/H/0105/001

4452884

FR/H/0105/001

5336987

PRONOVA BIOPHARMA

PT

PRONOVA BIOPHARMA

PT

PRONOVA BIOPHARMA

PT

NORGE AS FR/H/0105/001

4452983

cápsulas moles Omacor 1000 mg,

BE

NORGE AS

cápsulas moles Omacor 1000 mg,

PRONOVA BIOPHARMA

NORGE AS

cápsulas moles Omacor 1000 mg,

LU

NORGE AS

cápsulas moles Omacor 1000 mg,

PRONOVA BIOPHARMA NORGE AS

capsules Omacor 1000 mg,

BE

NORGE AS

Weichkapseln OMACOR 1000 mg zachte

PRONOVA BIOPHARMA

PRONOVA BIOPHARMA

PT

NORGE AS FR/H/0105/001

cápsulas moles

List of nationally authorised medicinal products EMA/639207/2017

4453080

PRONOVA BIOPHARMA

PT

NORGE AS

Page 5/10

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

OMACOR 1000 mg,

FR/H/0105/001

34009 339 435 3 0

PRONOVA BIOPHARMA

FR

capsule molle OMACOR 1000 mg,

NORGE AS FR/H/0105/001

34009 563 901 4 4

capsule molle OMACOR 1000 mg,

FR/H/105/001

34009 300 105 3 2

FR/H/105/001

34009 300 105 4 9

FR/H/105/001

34009 300 198 1 8

FR/H/0105/001

34009 357 025 8 6

FR/H/0105/001

517/00101

PRONOVA BIOPHARMA

FR

PRONOVA BIOPHARMA

FR

PRONOVA BIOPHARMA

MT

NORGE AS FR/H/0105/001

PL 15905/0001

capsules, soft Omacor kapsel, myk

FR

NORGE AS

capsules, soft Omacor 1000 mg,

PRONOVA BIOPHARMA

NORGE AS

capsule molle Omacor 1000 mg,

FR

NORGE AS

capsule molle Omacor 1000 mg,

PRONOVA BIOPHARMA NORGE AS

capsule molle OMACOR 1000 mg,

FR

NORGE AS

capsule molle OMACOR 1000 mg,

PRONOVA BIOPHARMA

PRONOVA BIOPHARMA

UK

NORGE AS not available

8041

PRONOVA BIOPHARMA

NO

NORGE AS

List of nationally authorised medicinal products EMA/639207/2017

Page 6/10

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Omacor, 1000 mg

FR/H/0105/001

430203

PRONOVA BIOPHARMA

EE

pehmekapslid Omacor, 1000 mg,

NORGE AS not available

4325/2004/01

capsule moi OMACOR, 1000 mg,

not available

4325/2004/03

not available

4325/2004/04

not available

4325/2004/02

FR/H/0105/001

12303

FR/H/0105/001

31/366/05-C

PRONOVA BIOPHARMA

RO

PRONOVA BIOPHARMA

PL

PRONOVA BIOPHARMA

CZ

NORGE AS FR/H/0105/001

RVG 28822

460 mg/380 mg Omacor® 1000 mg

RO

NORGE AS

měkké tobolky Omacor, zachte capsules,

PRONOVA BIOPHARMA

NORGE AS

kapsułki miękkie Omacor, 1000 mg,

RO

NORGE AS

capsule moi, Omacor, 1000 mg,

PRONOVA BIOPHARMA NORGE AS

capsule moi Omacor, 1000 mg,

RO

NORGE AS

capsule moi OMACOR, 1000 mg,

PRONOVA BIOPHARMA

PRONOVA BIOPHARMA

NL

NORGE AS FR/H/0105/001

Weichkapseln

List of nationally authorised medicinal products EMA/639207/2017

37312.00.00

PRONOVA BIOPHARMA

DE

NORGE AS

Page 7/10

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

OMACOR® 1000 mg,

FR/H/0105/001

20055

PRONOVA BIOPHARMA

CY

καψάκια, μαλακά OMACOR® καψάκιο,

NORGE AS FR/H/0105/001

3196/13-1-2009

μαλακό SEACOR 1000 mg

not available

027616034

SPA – SOCIETÀ PRODOTTI

IT

ANTIBIOTICI S.P.A. not available

027616022

Capsule molli SEACOR 500 mg Capsule

GR

(GREECE)

Capsule molli SEACOR 1000 mg

BGP PRODUCTS LTD

SPA – SOCIETÀ PRODOTTI

IT

ANTIBIOTICI S.P.A. not available

027616010

molli

SPA – SOCIETÀ PRODOTTI

IT

ANTIBIOTICI S.P.A.

Zidoril cápsula mole

not available

5550371

FERRER PORTUGAL, S.A.

PT

Zidoril cápsula mole

not available

5550405

FERRER PORTUGAL, S.A.

PT

Zodin 1000 mg -

FR/H/261/01

1-26485

PRONOVA BIOPHARMA

AT

Weichkapseln Zodin 1000 mg καψάκια,

NORGE AS FR/H/0261/001

77126/30-10-2015

FERRER-GALENICA S.A.

GR

μαλακά

List of nationally authorised medicinal products EMA/639207/2017

Page 8/10

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

ZODIN 1000 mg, capsule

FR/H/0261/001

34009 374 834 8 3

PRONOVA BIOPHARMA

FR

molle ZODIN 1000 mg, capsule

NORGE AS FR/H/0261/001

34009 361 971 1 4

molle ZODIN 1000 mg, capsule

FR/H/0261/001

34009 374 835 4 4

FR/H/0261/001

34009 564 880 0 1

FR/H/0261/001

34009 564 881 7 9

FR/H/261/01

5015839

FR/H/261/01

5409784

PRONOVA BIOPHARMA

FR

PRONOVA BIOPHARMA

PT

PRONOVA BIOPHARMA

PT

NORGE AS FR/H/261/01

5015847

mole ZODIN, 1000 mg cápsula

FR

NORGE AS

mole ZODIN, 1000 mg cápsula

PRONOVA BIOPHARMA

NORGE AS

mole ZODIN, 1000 mg cápsula

FR

NORGE AS

molle ZODIN, 1000 mg cápsula

PRONOVA BIOPHARMA NORGE AS

molle ZODIN 1000 mg, capsule

FR

NORGE AS

molle ZODIN 1000 mg, capsule

PRONOVA BIOPHARMA

PRONOVA BIOPHARMA

PT

NORGE AS FR/H/261/01

mole

List of nationally authorised medicinal products EMA/639207/2017

5409883

PRONOVA BIOPHARMA

PT

NORGE AS

Page 9/10

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Zodin, 1000 mg cápsula

FR/H/261/01

5409982

PRONOVA BIOPHARMA

PT

mole Zodin® Omega-3 1000

NORGE AS FR/H/0261/001

60885.00.00

mg Weichkapseln Омакор 1000 mg меки

PRONOVA BIOPHARMA

DE

NORGE AS not available

капсули

List of nationally authorised medicinal products EMA/639207/2017

20040231

PRONOVA BIOPHARMA

BG

NORGE AS

Page 10/10

omega-3-acid-ethyl esters - European Medicines Agency - Europa EU

Sep 29, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website www.ema.europa.eu/contact. © European ...

123KB Sizes 35 Downloads 251 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...